Literature DB >> 3456985

Pharmacokinetics of ofloxacin and theophylline alone and in combination.

J B Fourtillan, J Granier, B Saint-Salvi, J Salmon, A Surjus, D Tremblay, M Vincent Du Laurier, S Beck.   

Abstract

The pharmacokinetic interactions of ofloxacin (2 X 200 mg) and theophylline (3 X 200 mg) were investigated in 12 healthy volunteers over a period of two weeks. In the first week, theophylline was given over five days to reach a steady state. In the second week, the combination of theophylline and ofloxacin was applied. Cmax, tmax, AUC0-8, the serum elimination constant and serum half-life of theophylline were not changed when theophylline was given alone or in combination with ofloxacin. The kinetic parameters of ofloxacin were in accordance with data from the literature.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3456985     DOI: 10.1007/BF01645203

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  3 in total

1.  Convulsions and hyperglycaemia associated with nalidixic acid.

Authors:  A G Fraser; A D Harrower
Journal:  Br Med J       Date:  1977-12-10

2.  Quinolones and raised plasma concentrations of theophylline.

Authors:  F P Maesen; J P Teengs; C Baur; B I Davies
Journal:  Lancet       Date:  1984-09-01       Impact factor: 79.321

3.  Convulsions related to enoxacin.

Authors:  K J Simpson; M J Brodie
Journal:  Lancet       Date:  1985-07-20       Impact factor: 79.321

  3 in total
  24 in total

1.  Effects of 2 quinolone antibacterials, temafloxacin and enoxacin, on theophylline pharmacokinetics.

Authors:  F Sörgel; G Mahr; G R Granneman; U Stephan; P Nickel; P Muth
Journal:  Clin Pharmacokinet       Date:  1992       Impact factor: 6.447

2.  Effect of ciprofloxacin on antipyrine pharmacokinetics and metabolism in rats.

Authors:  A Anadón; M R Martinez-Larrañaga; M C Fernandez; M J Diaz; P Bringas
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

Review 3.  Pharmacokinetic interactions between theophylline and other medication (Part II).

Authors:  R A Upton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

Review 4.  Tolerability of fluoroquinolone antibiotics. Past, present and future.

Authors:  P Ball; G Tillotson
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

Review 5.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 6.  Mycobacteria and the new quinolones.

Authors:  D C Leysen; A Haemers; S R Pattyn
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

7.  Effect of norfloxacin on theophylline metabolism.

Authors:  R L Davis; H W Kelly; R W Quenzer; J Standefer; B Steinberg; J Gallegos
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

Review 8.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

9.  Interaction between oral ciprofloxacin and caffeine in normal volunteers.

Authors:  D P Healy; R E Polk; L Kanawati; D T Rock; M L Mooney
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

10.  Inhibition of theophylline clearance by coadministered ofloxacin without alteration of theophylline effects.

Authors:  S L Gregoire; T H Grasela; J P Freer; K J Tack; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.